Senior HEOR & Evidence Strategy Lead - Hematology (Remote)

Michael Page (Switzerland); Basel-Stadt; On-site; CHF 110,000 - 160,000; Full time

Benefits offered by this job

Remote work from Switzerland

6-9 month assignment with extension

Job summary

Michael Page International (Switzerland) SA is recruiting an experienced HEOR/HTA & Evidence Strategy Manager (Hematology) to lead EU Joint Clinical Assessment readiness for upcoming hematology launches in 2027. The role supports three assets across Europe, with a focus on evidence generation and strategic planning.

The position offers a 6-9 month contract with extension options and the possibility to work 100% remotely from Switzerland.

Qualifications

• Master's degree or PhD in Health Economics, Outcomes Research, Epidemiology, Public Health, Statistics or a related discipline.
• 5+ years of relevant experience in HEOR, HTA, RWE or comparative effectiveness research, preferably within the pharmaceutical industry or consulting.
• Good understanding of European HTA and evidence requirements; knowledge or experience with the EU HTA Regulation and JCA would be a strong asset.
• Experience with ITC/NMA and population-adjusted approaches (e.g. MAIC/STC) would be highly desirable.
• Experience designing, managing and critically reviewing HEOR studies and working with external research vendors.
• Knowledge or experience in hematology/oncology would be an asset.

Responsibilities

• Leading HEOR support for three hematology assets in Europe, including two anticipated launches in 2027, with a strong focus on EU Joint Clinical Assessment (JCA) preparedness.
• Coordinating cross-functional JCA planning and execution across Market Access, Clinical Development, Regulatory Affairs, Safety, Medical Affairs, Biostatistics, and Global teams.
• Supporting the development and implementation of evidence strategies to address JCA, HTA, reimbursement, and broader market access requirements.
• Identifying evidence gaps and translating JCA/PICO requirements into evidence-generation plans and priorities.
• Supporting JCA PICO assessment and planning, including evaluation of target populations, comparators, outcomes, and evidence availability.
• Leading the coordination and review of externally generated evidence packages, including indirect treatment comparisons, real-world evidence studies, and other HEOR analyses.
• Managing external HEOR and evidence-generation vendors, ensuring delivery of high-quality outputs aligned with JCA timelines and business needs.
• Reviewing study protocols, analysis plans, reports, and evidence deliverables to ensure methodological appropriateness and strategic relevance.
• Facilitating alignment among internal stakeholders on evidence-generation priorities, assumptions, and interpretation of results.
• Supporting the communication of evidence and key findings to internal stakeholders to inform HTA and access strategies.
• Contributing to JCA readiness activities for upcoming hematology launches and supporting broader portfolio priorities as needed.

Skills

HEOR/HTA

RWE

EU HTA / JCA

Cross-functional coordination

English proficiency

Education

Master's/PhD in Health Economics/Outcomes Research

Job description

Michael Page International (Switzerland) SA is recruiting an experienced HEOR/HTA & Evidence Strategy Manager (Hematology) to lead EU Joint Clinical Assessment readiness for upcoming hematology launches in 2027. The role supports three assets across Europe, with a focus on evidence generation and strategic planning.

The position offers a 6-9 month contract with extension options and the possibility to work 100% remotely from Switzerland.